Department of Obstetrics and Gynecology, Division of Gynecologic Endoscopy, Chang Gung Memorial Hospital at Linkou and Chang Gung University, Taiwan.
Taiwan J Obstet Gynecol. 2010 Dec;49(4):401-6. doi: 10.1016/S1028-4559(10)60089-7.
The robotic surgical system is reported to overcome some technical difficulties in traditional laparoscopic hysterectomy. This study aimed to evaluate the feasibility and surgical outcomes of a robotic surgery program for endometrial cancer.
Patients with endometrial cancer with the intention to receive treatment using robot-assisted laparoscopic staging surgery were recruited in a university hospital from July 2007 to August 2008. All of these surgeries were performed with the da Vinci system.
Six patients (mean age, 47.5 ±1.4 years; mean body mass index, 26.2 ±3.5 kg/m(2)) were enrolled and completed robot-assisted laparoscopic staging surgery. The robot docking time was 45.0 ±13.6 minutes and the robot-assisted operation time was 200.3 ±30.0 minutes. The mean estimated blood loss was 180.0 ±147.6 mL. The mean number of lymph nodes retrieved was 23.2 ±7.4. No laparoconversion and no intraoperative or postoperative complications occurred. All patients were alive and free of disease up to the date of this report, at a median follow-up of 6.5 months (range, 5-17 months).
Robot-assisted laparoscopic staging surgery is a feasible treatment and helps overcome the technical limitations in conventional laparoscopy for endometrial cancer.
机器人手术系统据称可克服传统腹腔镜子宫切除术的一些技术难题。本研究旨在评估机器人手术用于子宫内膜癌分期手术的可行性和手术结果。
2007 年 7 月至 2008 年 8 月，一家大学医院招募了计划接受机器人辅助腹腔镜分期手术治疗的子宫内膜癌患者。所有手术均使用达芬奇系统进行。
纳入 6 例患者（平均年龄 47.5 ±1.4 岁；平均体重指数 26.2 ±3.5 kg/m²），均完成了机器人辅助腹腔镜分期手术。机器人对接时间为 45.0 ±13.6 分钟，机器人辅助手术时间为 200.3 ±30.0 分钟。平均估计出血量为 180.0 ±147.6 mL。平均取出的淋巴结数为 23.2 ±7.4 个。无腹腔镜中转，无术中或术后并发症发生。截至本报告日期，所有患者均存活且无疾病，中位随访时间为 6.5 个月（范围为 5-17 个月）。
机器人辅助腹腔镜分期手术是一种可行的治疗方法，有助于克服子宫内膜癌常规腹腔镜手术的技术限制。
